LYEL
Closed
Lyell Immunopharma Inc
9.425
+0.585 (+6.62%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 8.84
Day's Range: 8.87 - 9.62
Send
sign up or login to leave a comment!
When Written:
2.79
Lyell Immunopharma Inc is a biotechnology company that focuses on the development of personalized cell therapies for cancer treatment. The company was founded in 2018 and is headquartered in South San Francisco, California.
Lyell Immunopharma's approach to cancer treatment involves using a patient's own immune cells to target and destroy cancer cells. The company's technology platform includes advanced cell engineering and manufacturing capabilities, as well as proprietary bioinformatics tools to identify optimal targets for personalized cell therapies.
Lyell Immunopharma has partnerships with several leading academic institutions and biopharmaceutical companies to advance the development of its cell therapies. The company has also received significant funding from investors, including a $493 million Series C financing round in 2021.
Lyell Immunopharma's mission is to improve the lives of cancer patients by developing innovative, personalized cell therapies that can provide long-term remissions and potentially cure the disease.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Lyell Immunopharma's approach to cancer treatment involves using a patient's own immune cells to target and destroy cancer cells. The company's technology platform includes advanced cell engineering and manufacturing capabilities, as well as proprietary bioinformatics tools to identify optimal targets for personalized cell therapies.
Lyell Immunopharma has partnerships with several leading academic institutions and biopharmaceutical companies to advance the development of its cell therapies. The company has also received significant funding from investors, including a $493 million Series C financing round in 2021.
Lyell Immunopharma's mission is to improve the lives of cancer patients by developing innovative, personalized cell therapies that can provide long-term remissions and potentially cure the disease.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








